Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.
Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis: A Randomized Control Trial
Sponsor: Institute of Liver and Biliary Sciences, India
This NA trial investigates Non Alcoholic Steatohepatitis and is currently ongoing. Institute of Liver and Biliary Sciences, India leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Mar 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Mar 2020 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Dec 2017 [monthly]
Recruiting NA
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institute of Liver and Biliary Sciences, India
For direct contact, visit the study record on ClinicalTrials.gov .